Q4 2022 Poxel SA Earnings Call Transcript
(technical difficulty)
(Operator Instructions) I now hand over to Thomas.
Thank you, Nicolas. Hey, everyone, and good morning, good afternoon. Thank you for joining us today. I'm Thomas Kuhn, the CEO of Poxel. After my introductory comments, highlighting our key achievements of 2022 and early 2023, I will go into the details of today's announcement where we did our debt restructuring and a new equity linked financing. And I will give you an update on the recent trend of TWYMEEG sales, our lead product. I will then review the full year 2022 financial results.
Before leaving the floor to David, our Chief Scientific Officer. David will provide an update on our clinical pipeline and will then conclude and open the call for questions.
Before we begin, this is our forward-looking statement. Forward-looking statements are subject to inherent risks and uncertainties beyond the company's control that could cause the company's actual results or performance to be materially different
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |